Organon & Co
General ticker "OGN" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $3.9B
Organon & Co follows the US Stock Market performance with the rate: 13.7%.
Estimated limits based on current volatility of 1.9%: low 14.40$, high 14.96$
Factors to consider:
- Company pays dividends: last record date 2024-11-12, amount 0.28$ (Y7.68%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [7.53$, 15.07$]
- 2024-12-30 to 2025-12-30 estimated range: [6.25$, 12.48$]
Short-term OGN quotes
Long-term OGN plot with estimates
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $6,263.00MM |
| Operating Expenses | $4,936.00MM |
| Operating Income | $1,327.00MM |
| Non-Operating Income | $-654.00MM |
| Interest Expense | $527.00MM |
| R&D Expense | $528.00MM |
| Income(Loss) | $673.00MM |
| Taxes | $-350.00MM |
| Profit(Loss) | $1,023.00MM |
| Stockholders Equity | $-70.00MM |
| Inventory | $1,315.00MM |
| Assets | $12,058.00MM |
| Operating Cash Flow | $799.00MM |
| Capital expenditure | $261.00MM |
| Investing Cash Flow | $-260.00MM |
| Financing Cash Flow | $-569.00MM |
| Earnings Per Share* | $4.01 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.